KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Gross Margin (2019 - 2026)

GoodRx Holdings' Gross Margin history spans 7 years, with the latest figure at 200.29% for Q4 2025.

  • On a quarterly basis, Gross Margin rose 26702.0% to 200.29% in Q4 2025 year-over-year; TTM through Dec 2025 was 92.77%, a 3911.0% increase, with the full-year FY2025 number at 92.77%, up 3911.0% from a year prior.
  • Gross Margin hit 200.29% in Q4 2025 for GoodRx Holdings, up from 57.39% in the prior quarter.
  • Over the last five years, Gross Margin for GDRX hit a ceiling of 200.29% in Q4 2025 and a floor of 66.73% in Q4 2024.
  • Historically, Gross Margin has averaged 70.4% across 5 years, with a median of 58.28% in 2025.
  • Biggest five-year swings in Gross Margin: plummeted -11905bps in 2024 and later soared 26702bps in 2025.
  • Tracing GDRX's Gross Margin over 5 years: stood at 50.06% in 2021, then grew by 8bps to 54.31% in 2022, then decreased by -4bps to 52.32% in 2023, then crashed by -228bps to 66.73% in 2024, then soared by 400bps to 200.29% in 2025.
  • Business Quant data shows Gross Margin for GDRX at 200.29% in Q4 2025, 57.39% in Q3 2025, and 58.21% in Q2 2025.